mardi 28 mars 2017

Severe Eczema Drug Is Approved by F.D.A.; Price Tag Is $37,000 a Year

The drug makers Regeneron Pharmaceuticals and Sanofi made a rare move, negotiating with insurers in advance over the price for Dupixent.

from NYT > Health http://ift.tt/2nxrsrZ
via health&fitness

Aucun commentaire:

Enregistrer un commentaire